Form 8-K - Current report:
SEC Accession No. 0001213900-25-066618
Filing Date
2025-07-22
Accepted
2025-07-22 16:05:35
Documents
14
Period of Report
2025-07-18
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0249778-8k_pmgc.htm   iXBRL 8-K 30542
2 ACQUISITION AGREEMENT DATED AS OF JULY 18, 2025, BY AND BETWEEN PMGC HOLDINGS IN ea024977801ex10-1_pmgc.htm EX-10.1 148534
3 PRESS RELEASE OF PMGC HOLDINGS INC. DATED AS OF JULY 18, 2025 ea024977801ex99-1_pmgc.htm EX-99.1 15098
  Complete submission text file 0001213900-25-066618.txt   401865

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE elab-20250718.xsd EX-101.SCH 3026
5 XBRL LABEL FILE elab-20250718_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE elab-20250718_pre.xml EX-101.PRE 22366
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0249778-8k_pmgc_htm.xml XML 3807
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 888-445-4886
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 251140352
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)